Trial intelligence / Profile preview

GLP-1 vs Insulin for Normoglycemia in Type 2 Diabetes

NCT00859079Phase 4Completed

Sponsor
Medical University of Graz
Start
Jun 2006
Primary completion
Dec 2006
Modality
Peptides, Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of Glucagon-like peptide 1 in type 2 diabetes mellitus (T2DM), hyperglycemia, sponsored by Medical University of Graz. Started Jun 2006; status: completed.

02

Drugs

Glucagon-like peptide 1
03

Conditions

type 2 diabetes mellitus (T2DM)hyperglycemia

Beyond the preview

Go deeper on NCT00859079.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00859079.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call